VPIM
Vanguard Personalized Indexing Management Portfolio holdings
AUM
$8.86B
1-Year Return
26.43%
This Quarter Return
-2.18%
1 Year Return
+26.43%
3 Year Return
+118.27%
5 Year Return
+211.61%
10 Year Return
–
AUM
$6.78B
AUM Growth
+$161M
(+2.4%)
Cap. Flow
+$471M
Cap. Flow
% of AUM
6.95%
Top 10 Holdings %
Top 10 Hldgs %
28.84%
Holding
1,935
New
129
Increased
1,230
Reduced
459
Closed
96
Top Buys
| 1 |
Apple
AAPL
|
+$27.3M |
| 2 |
NVIDIA
NVDA
|
+$13M |
| 3 |
Amazon
AMZN
|
+$11.5M |
| 4 |
Johnson & Johnson
JNJ
|
+$11.5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$8.49M |
Top Sells
| 1 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$1.66M |
| 2 |
Vanguard Total World Stock ETF
VT
|
+$1.57M |
| 3 |
General Mills
GIS
|
+$1.25M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$1.08M |
| 5 |
Lockheed Martin
LMT
|
+$889K |
Sector Composition
| 1 | Technology | 29.44% |
| 2 | Financials | 14.94% |
| 3 | Healthcare | 10.98% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
ChargePoint
CHPT
$245M
| $37.5K | ﹤0.01% |
3,095
+2,079
| +205% | +$25.2K |
|
1702
Sabre
SABR
$698M
| $36.9K | ﹤0.01% |
13,149
+1,314
| +11% | +$3.69K |
|
1703
Allogene Therapeutics
ALLO
$253M
| $36.9K | ﹤0.01% |
25,290
+4,777
| +23% | +$6.97K |
|
|
GPMT
1704
Granite Point Mortgage Trust
GPMT
$144M
| $36.7K | ﹤0.01% |
14,123
-47
| -0.3% | -$122 |
|
1705
Altice USA
ATUS
$1.12B
| $36.2K | ﹤0.01% |
13,622
+321
| +2% | +$854 |
|
1706
Relay Therapeutics
RLAY
$702M
| $36.2K | ﹤0.01% |
13,802
-3,723
| -21% | -$9.75K |
|
1707
Pacific Biosciences
PACB
$393M
| $35.9K | ﹤0.01% |
30,425
+26
| +0.1% | +$31 |
|
1708
RAPT Therapeutics
RAPT
$225M
| $35.7K | ﹤0.01% |
3,661
-46
| -1% | -$449 |
|
1709
Seres Therapeutics
MCRB
$163M
| $35.5K | ﹤0.01% |
2,536
-1,021
| -29% | -$14.3K |
|
1710
Gevo
GEVO
$389M
| $35.3K | ﹤0.01% |
30,418
-10,300
| -25% | -$11.9K |
|
1711
Virgin Galactic
SPCE
$183M
| $35.1K | ﹤0.01% |
+11,583
| New | +$35.1K |
|
1712
Kodiak Sciences
KOD
$531M
| $34.7K | ﹤0.01% |
12,379
+561
| +5% | +$1.57K |
|
1713
Heron Therapeutics
HRTX
$199M
| $34.7K | ﹤0.01% |
15,759
-18
| -0.1% | -$40 |
|
1714
Solid Power
SLDP
$685M
| $34.4K | ﹤0.01% |
32,809
+19,120
| +140% | +$20.1K |
|
1715
Fate Therapeutics
FATE
$113M
| $34.1K | ﹤0.01% |
43,096
+28,324
| +192% | +$22.4K |
|
1716
PDS Biotechnology
PDSB
$55.5M
| $33.9K | ﹤0.01% |
+28,523
| New | +$33.9K |
|
1717
Shoals Technologies Group
SHLS
$1.11B
| $33.7K | ﹤0.01% |
10,157
+48
| +0.5% | +$159 |
|
1718
EVgo
EVGO
$525M
| $32.9K | ﹤0.01% |
12,375
+948
| +8% | +$2.52K |
|
|
CAN
1719
Canaan Creative
CAN
$345M
| $32.6K | ﹤0.01% |
37,160
-3,775
| -9% | -$3.31K |
|
1720
indie Semiconductor
INDI
$804M
| $32.1K | ﹤0.01% |
15,770
+3,612
| +30% | +$7.35K |
|
1721
C4 Therapeutics
CCCC
$191M
| $31.4K | ﹤0.01% |
+19,595
| New | +$31.4K |
|
1722
Origin Materials
ORGN
$78.5M
| $31.1K | ﹤0.01% |
46,923
+730
| +2% | +$484 |
|
1723
Digital Turbine
APPS
$495M
| $30.9K | ﹤0.01% |
11,385
-85
| -0.7% | -$231 |
|
1724
Editas Medicine
EDIT
$248M
| $30.9K | ﹤0.01% |
26,601
+16,032
| +152% | +$18.6K |
|
1725
Lightwave Logic
LWLG
$400M
| $30.8K | ﹤0.01% |
+30,079
| New | +$30.8K |
|